taurine has been researched along with Nervous System Disorders in 20 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study evaluated the potentiation by glycine of anticonvulsant drugs in maximal electroshock seizures in rats." | 7.68 | Potentiation by glycine of anticonvulsant drugs in maximal electroshock seizures in rats. ( Adams, HR; Frye, GD; Peterson, SL; Trzeciakowski, JP, 1990) |
| "The tremorogenic effect of high pressure was antagonized in guinea pigs by intravenous treatment with taurine in doses of 250 and 500 mg/kg." | 7.67 | Antagonism by taurine of pressure-induced tremor in the guinea pig. ( Ackerman, MJ; Bradley, ME; Gilman, SC; Hallenbeck, JM, 1984) |
| "This study evaluated the potentiation by glycine of anticonvulsant drugs in maximal electroshock seizures in rats." | 3.68 | Potentiation by glycine of anticonvulsant drugs in maximal electroshock seizures in rats. ( Adams, HR; Frye, GD; Peterson, SL; Trzeciakowski, JP, 1990) |
| "The tremorogenic effect of high pressure was antagonized in guinea pigs by intravenous treatment with taurine in doses of 250 and 500 mg/kg." | 3.67 | Antagonism by taurine of pressure-induced tremor in the guinea pig. ( Ackerman, MJ; Bradley, ME; Gilman, SC; Hallenbeck, JM, 1984) |
| "Taurine is a fundamental mediator of homeostasis that exerts multiple roles to confer protection against oxidant stress." | 2.72 | Protective role of taurine against oxidative stress (Review). ( Adamaki, M; Baliou, S; Christodoulou, I; Ioannou, P; Kyriakopoulos, AM; Panayiotidis, MI; Pappa, A; Spandidos, DA; Zoumpourlis, V, 2021) |
| "Taurine is a sulfur-containing amino acid and known as semi-essential in mammals and is produced chiefly by the liver and kidney." | 2.61 | Taurine and its analogs in neurological disorders: Focus on therapeutic potential and molecular mechanisms. ( Azam, S; Choi, DK; Haque, ME; Jakaria, M; Jo, SH; Kim, IS; Uddin, MS, 2019) |
| "Taurine plays multiple roles in the CNS including acting as a -neuro-modulator, an osmoregulator, a regulator of cytoplasmic calcium levels, a trophic factor in development, and a neuroprotectant." | 2.49 | Taurine and its neuroprotective role. ( Kumari, N; Prentice, H; Wu, JY, 2013) |
| "Taurine has demonstrated promising actions in vitro, and as a result clinical trials have begun to investigate its effects on various diseases." | 2.43 | Is taurine a functional nutrient? ( Bouckenooghe, T; Remacle, C; Reusens, B, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (35.00) | 18.7374 |
| 1990's | 3 (15.00) | 18.2507 |
| 2000's | 4 (20.00) | 29.6817 |
| 2010's | 5 (25.00) | 24.3611 |
| 2020's | 1 (5.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baliou, S | 1 |
| Adamaki, M | 1 |
| Ioannou, P | 1 |
| Pappa, A | 1 |
| Panayiotidis, MI | 1 |
| Spandidos, DA | 1 |
| Christodoulou, I | 1 |
| Kyriakopoulos, AM | 1 |
| Zoumpourlis, V | 1 |
| Jakaria, M | 1 |
| Azam, S | 1 |
| Haque, ME | 1 |
| Jo, SH | 1 |
| Uddin, MS | 1 |
| Kim, IS | 1 |
| Choi, DK | 1 |
| Zhang, Z | 1 |
| Yu, R | 1 |
| Cao, L | 1 |
| Takeda, A | 1 |
| Itoh, H | 1 |
| Tamano, H | 1 |
| Yuzurihara, M | 1 |
| Oku, N | 1 |
| Sinha, M | 1 |
| Manna, P | 1 |
| Sil, PC | 2 |
| Sun, M | 1 |
| Gu, Y | 1 |
| Zhao, Y | 1 |
| Xu, C | 1 |
| Das, J | 1 |
| Roy, A | 1 |
| Kumari, N | 1 |
| Prentice, H | 1 |
| Wu, JY | 1 |
| Dawson, R | 1 |
| Bouckenooghe, T | 1 |
| Remacle, C | 1 |
| Reusens, B | 1 |
| Redford-Ellis, M | 1 |
| Gibbs, AC | 1 |
| Haider, SA | 1 |
| Holzel, A | 1 |
| Gilman, SC | 1 |
| Hallenbeck, JM | 1 |
| Ackerman, MJ | 1 |
| Bradley, ME | 1 |
| Laube, B | 1 |
| Langosch, D | 1 |
| Betz, H | 1 |
| Schmieden, V | 1 |
| Jacobsen, JG | 1 |
| Trenkner, E | 1 |
| Peterson, SL | 1 |
| Trzeciakowski, JP | 1 |
| Frye, GD | 1 |
| Adams, HR | 1 |
| Wiechert, P | 1 |
| De Deyn, P | 1 |
| Marescau, B | 1 |
| Lowenthal, A | 1 |
| Airaksinen, EM | 1 |
| Partanen, J | 1 |
| Brogi, L | 1 |
| Avesani, A | 1 |
| Bergamini, L | 1 |
6 reviews available for taurine and Nervous System Disorders
| Article | Year |
|---|---|
Protective role of taurine against oxidative stress (Review).
Topics: Animals; Antioxidants; Heart Diseases; Homeostasis; Humans; Liver Diseases; Muscular Diseases; Nervo | 2021 |
Taurine and its analogs in neurological disorders: Focus on therapeutic potential and molecular mechanisms.
Topics: Animals; Humans; Nervous System Diseases; Taurine | 2019 |
Mechanism of the protective action of taurine in toxin and drug induced organ pathophysiology and diabetic complications: a review.
Topics: Animals; Antioxidants; Arsenic; Blood Pressure; Cadmium; Calcium; Chemical and Drug Induced Liver In | 2012 |
Taurine and its neuroprotective role.
Topics: Animals; Endoplasmic Reticulum Stress; Humans; Mitochondria; Nervous System Diseases; Neuroprotectiv | 2013 |
Taurine in aging and models of neurodegeneration.
Topics: Aged; Aging; Humans; Nervous System; Nervous System Diseases; Taurine | 2003 |
Is taurine a functional nutrient?
Topics: Animals; Diabetes Mellitus, Type 2; Humans; Immunologic Factors; Liver Diseases; Nervous System Dise | 2006 |
14 other studies available for taurine and Nervous System Disorders
| Article | Year |
|---|---|
Neuroprotection of taurine through inhibition of 12/15 lipoxygenase pathway in cerebral ischemia of rats.
Topics: Animals; Arachidonate 12-Lipoxygenase; Arachidonate 15-Lipoxygenase; Brain Edema; Brain Infarction; | 2017 |
Suppressive effect of Yokukansan on excessive release of glutamate and aspartate in the hippocampus of zinc-deficient rats.
Topics: Animals; Aspartic Acid; Drugs, Chinese Herbal; Extracellular Fluid; Glutamic Acid; Glycine; Hippocam | 2008 |
Cadmium-induced neurological disorders: prophylactic role of taurine.
Topics: Animals; Antioxidants; Ascorbic Acid; Body Weight; Brain; Cadmium Chloride; DNA Fragmentation; Dose- | 2008 |
Protective functions of taurine against experimental stroke through depressing mitochondria-mediated cell death in rats.
Topics: Adenosine Triphosphate; Animals; bcl-2-Associated X Protein; bcl-X Protein; Brain Ischemia; Calpain; | 2011 |
Aminoaciduria in handicapped children: a study using ion-exchange chromatography as a screening test.
Topics: Amino Acids; Child; Child, Preschool; Chromatography, Ion Exchange; Cystathionine; Developmental Dis | 1981 |
Antagonism by taurine of pressure-induced tremor in the guinea pig.
Topics: Animals; Atmospheric Pressure; Differential Threshold; Electroencephalography; Guinea Pigs; Male; Ne | 1984 |
Hyperekplexia mutations of the glycine receptor unmask the inhibitory subsite for beta-amino-acids.
Topics: Animals; beta-Alanine; Glycine; Humans; Ligands; Membranes; Mutation; Nervous System Diseases; Oocyt | 1995 |
[2. International symposium on taurine. Tucson, Arizona 28.-30.III.1977].
Topics: Central Nervous System; Humans; Myocardium; Nervous System Diseases; Retina; Taurine | 1977 |
The role of taurine and glutamate during early postnatal cerebellar development of normal and weaver mutant mice.
Topics: Animals; Astrocytes; Cerebellum; Glutamates; Glutamic Acid; In Vitro Techniques; Mice; Mice, Neurolo | 1990 |
Potentiation by glycine of anticonvulsant drugs in maximal electroshock seizures in rats.
Topics: Animals; Anticonvulsants; Brain Chemistry; Carbamazepine; Chromatography, High Pressure Liquid; Diaz | 1990 |
Taurocyamine in cerebrospinal fluid of neurological and psychiatric patients.
Topics: Humans; Mental Disorders; Nervous System Diseases; Taurine | 1986 |
Muscle taurine in chicken and diseased human muscle.
Topics: Adolescent; Adult; Aged; Animals; Chickens; Child; Child, Preschool; Female; Humans; Infant; Male; M | 1985 |
[Research on the value of a taurine, nucleotide and vitamin combination in neurologic diseases].
Topics: Adenosine Monophosphate; Adenosine Triphosphate; Drug Combinations; Drug Evaluation; Female; Humans; | 1974 |
[Therapeutic use in the neurological field of a new pharmaceutical compound: monophosphate nucleotide (AMP and UMP) with taurine, pyridoxine and cyanocobalamine].
Topics: Adult; Aged; Female; Humans; Male; Middle Aged; Nervous System Diseases; Pyridoxine; Taurine; Vitami | 1967 |